Загрузка...

Therapeutic Sequencing in Metastatic Renal Cell Carcinoma

The influx of multiple novel therapeutic options in the mRCC field has brought a challenge for treatment sequencing in this disease. In the past few years, cabozantinib, nivolumab and the combination of lenvatinib and everolimus have been approved in the second-line setting. As there is no direct co...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Kidney Cancer
Главные авторы: Maia, Manuel Caitano, Dizman, Nazli, Salgia, Meghan, Pal, Sumanta Kumar
Формат: Artigo
Язык:Inglês
Опубликовано: IOS Press 2017
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6179120/
https://ncbi.nlm.nih.gov/pubmed/30334001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/KCA-170006
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!